Literature DB >> 2011536

Immunoglobulin variable heavy chain cDNA sequence from a patient with X-linked agammaglobulinemia.

F Mortari1, H D Ochs, R J Wedgwood, H W Schroeder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2011536      PMCID： PMC333664          DOI： 10.1093/nar/19.3.673

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  11 in total

1.  Preferential utilization of conserved immunoglobulin heavy chain variable gene segments during human fetal life.

Authors:  H W Schroeder; J Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

2.  Immunoglobulin heavy chain gene rearrangements in X-linked agammaglobulinemia.

Authors:  E J Mensink; R K Schuurman; J D Schot; A Thompson; F W Alt
Journal:  Eur J Immunol       Date:  1986-08       Impact factor: 5.532

3.  A novel family of variable region genes of the human immunoglobulin heavy chain.

Authors:  K H Lee; F Matsuda; T Kinashi; M Kodaira; T Honjo
Journal:  J Mol Biol       Date:  1987-06-20       Impact factor: 5.469

4.  Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia.

Authors:  D Campana; J Farrant; N Inamdar; A D Webster; G Janossy
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

Review 5.  The primary immunodeficiencies. (2).

Authors:  F S Rosen; M D Cooper; R J Wedgwood
Journal:  N Engl J Med       Date:  1984-08-02       Impact factor: 91.245

6.  Only DFL16, DSP2, and DQ52 gene families exist in mouse immunoglobulin heavy chain diversity gene loci, of which DFL16 and DSP2 originate from the same primordial DH gene.

Authors:  Y Ichihara; H Hayashida; S Miyazawa; Y Kurosawa
Journal:  Eur J Immunol       Date:  1989-10       Impact factor: 5.532

7.  Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation.

Authors:  H Gu; I Förster; K Rajewsky
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

8.  Organization of human immunoglobulin heavy chain diversity gene loci.

Authors:  Y Ichihara; H Matsuoka; Y Kurosawa
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

9.  The smaller human VH gene families display remarkably little polymorphism.

Authors:  I Sanz; P Kelly; C Williams; S Scholl; P Tucker; J D Capra
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

10.  Clonal diversity in the B cell repertoire of patients with X-linked agammaglobulinemia.

Authors:  R Anker; M E Conley; B A Pollok
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307
View more
  5 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 2.  B-cell receptor repertoire sequencing in patients with primary immunodeficiency: a review.

Authors:  Marie Ghraichy; Jacob D Galson; Dominic F Kelly; Johannes Trück
Journal:  Immunology       Date:  2017-12-18       Impact factor: 7.397

3.  Bone marrow cells in X-linked agammaglobulinemia express pre-B-specific genes (lambda-like and V pre-B) and present immunoglobulin V-D-J gene usage strongly biased to a fetal-like repertoire.

Authors:  M Milili; F Le Deist; G de Saint-Basile; A Fischer; M Fougereau; C Schiff
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  B cell repertoire in patients with a novel BTK mutation: expanding the spectrum of atypical X-linked agammaglobulinemia.

Authors:  Yu Nee Lee; Amit Nahum; Ori Toker; Arnon Broides; Atar Lev; Amos J Simon; Orli Megged; Oded Shamriz; Yuval Tal; Raz Somech
Journal:  Immunol Res       Date:  2022-01-10       Impact factor: 2.829

5.  Diversification, not use, of the immunoglobulin VH gene repertoire is restricted in DiGeorge syndrome.

Authors:  R N Haire; R D Buell; R T Litman; Y Ohta; S M Fu; T Honjo; F Matsuda; M de la Morena; J Carro; R A Good
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.